Philadelphia’s Complex Litigation Center has shed hundreds of cases from its docket in recent months as what was once its dominant mass tort program winds down.
With a clearing of cases in the center’s Risperdal litigation, Philadelphia’s mass tort inventory is now down more than 60% from the start of 2020, according to court data.
